A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...

A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...

One of the most sought-after vaccines in medicine is the HIV vaccine. When HIV was first discovered in 1981, scientists were optimistic that they would be able to develop a vaccine in a few years.

The project, aptly named BRILLIANT, an acronym for “Bringing Innovation to Clinical and Laboratory Research to End HIV in ...

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

Nigeria, South Africa, Zambia, Zimbabwe, Tanzania, Uganda, Kenya, and Mozambique have begun locally-led HIV vaccine research and development. This was disclosed at a press briefing in Abuja ...

The study reconfirms longstanding priorities for vaccine research and development, including HIV, malaria and tuberculosis – ...

The National Agency for the Control of AIDS (NACA has expressed enthusiasm over the involvement of an indigenous research institute in groundbreaking HIV vaccine development efforts. This comes ...

Ministers also deliberated on vaccine-preventable diseases especially and emphasized ... The ministers also endorsed the 2024 SADC HIV and AIDS Epidemic report and urged member states to implement the ...

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...